Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Kim, Seon Kyu ^a   Kim, Eun Jung ^a,b   Leem, Sun Hee ^c   Ha, Yun Sok ^a   Kim, Yong June ^a,b   Kim, Wun Jae ^a,b  

^a Chungbuk National University College of Medicine   (South Korea)

^b Chungbuk National University   (South Korea)

^c Dong A University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GROWTH; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC CORRELATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONMUSCLE INVASIVE BLADDER CANCER; PATHOGENESIS; PREDICTION; PROGNOSIS; BIOLOGICAL MODEL; BIOSYNTHESIS; BLADDER TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; CALGRANULIN A; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; URINARY BLADDER NEOPLASMS;

EID: 77649121655     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-21     Document Type: Article

References (41)

1. Pow-Sang JM, Seigne JD. Contemporary management of superficial bladder cancer. Cancer Control 2000, 7(4):335-339.
2. Holmang S, Johansson SL. Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. J Urol 2002, 167(4):1634-1637. 10.1016/S0022-5347(05)65168-3, 11912378.
3. Herr HW. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol 2000, 163(1):60-61. 10.1016/S0022-5347(05)67972-4, 10604314.
4. Liou LS. Urothelial cancer biomarkers for detection and surveillance. Urology 2006, 67(3 Suppl 1):25-33. 10.1016/j.urology.2006.01.034, 16530072.
5. Cordon-Cardo C, Zhang ZF, Dalbagni G, Drobnjak M, Charytonowicz E, Hu SX, Xu HJ, Reuter VE, Benedict WF. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res 1997, 57(7):1217-1221.
6. Habuchi T, Marberger M, Droller MJ, Hemstreet GP, Grossman HB, Schalken JA, Schmitz-Drager BJ, Murphy WM, Bono AV, Goebell P, et al. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 2005, 66(6 Suppl 1):64-74. 10.1016/j.urology.2005.08.065, 16399416.
7. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003, 4(7):517-529. 10.1038/nrm1155, 12838335.
8. Schafer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996, 21(4):134-140.
9. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001, 33(7):637-668. 10.1016/S1357-2725(01)00046-2, 11390274.
10. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003, 60(6):540-551. 10.1002/jemt.10296, 12645002.
11. Heizmann CW, Fritz G, Schafer BW. S100 proteins: structure, functions and pathology. Front Biosci 2002, 7:d1356-1368. 10.2741/heizmann, 11991838.
12. Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004, 322(4):1111-1122. 10.1016/j.bbrc.2004.07.096, 15336958.
13. Ravasi T, Hsu K, Goyette J, Schroder K, Yang Z, Rahimi F, Miranda LP, Alewood PF, Hume DA, Geczy C. Probing the S100 protein family through genomic and functional analysis. Genomics 2004, 84(1):10-22. 10.1016/j.ygeno.2004.02.002, 15203200.
14. Schafer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 1995, 25(3):638-643. 10.1016/0888-7543(95)80005-7, 7759097.
15. Schutte BC, Carpten JD, Forus A, Gregory SG, Horii A, White PS. Report and abstracts of the sixth international workshop on human chromosome 1 mapping 2000. Iowa City, Iowa, USA. 30 September-3 October 2000. Cytogenet Cell Genet 2001, 92(1-2):23-41. 10.1159/000056867, 11306795.
16. Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res 2006, 312(2):184-197. 10.1016/j.yexcr.2005.10.013, 16297907.
17. Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, Trojan L, Angel P, Mayer D. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res 2005, 11(14):5146-5152. 10.1158/1078-0432.CCR-05-0352, 16033829.
18. Stulik J, Koupilova K, Osterreicher J, Knizek J, Macela A, Bures J, Jandik P, Langr F, Dedic K, Jungblut PR. Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis 1999, 20(18):3638-3646. 10.1002/(SICI)1522-2683(19991201)20:18<3638::AID-ELPS3638>3.0.CO;2-W, 10612291.
19. Stulik J, Osterreicher J, Koupilova K, Knizek, Macela A, Bures J, Jandik P, Langr F, Dedic K, Jungblut PR. The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass. Electrophoresis 1999, 20(4-5):1047-1054. 10.1002/(SICI)1522-2683(19990101)20:4/5<1047::AID-ELPS1047>3.0.CO;2-E , 10344284.
20. Yong HY, Moon A. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch Pharm Res 2007, 30(1):75-81. 10.1007/BF02977781, 17328245.
21. Yao R, Lopez-Beltran A, Maclennan GT, Montironi R, Eble JN, Cheng L. Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res 2007, 27(5A):3051-3058.
22. Tolson JP, Flad T, Gnau V, Dihazi H, Hennenlotter J, Beck A, Mueller GA, Kuczyk M, Mueller CA. Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. Proteomics 2006, 6(2):697-708. 10.1002/pmic.200500033, 16252305.
23. Yao R, Davidson DD, Lopez-Beltran A, MacLennan GT, Montironi R, Cheng L. The S100 proteins for screening and prognostic grading of bladder cancer. Histol Histopathol 2007, 22(9):1025-1032.
24. Cross SS, Hamdy FC, Deloulme JC, Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005, 46(3):256-269. 10.1111/j.1365-2559.2005.02097.x, 15720411.
25. Rafii S, Lyden D. S100 chemokines mediate bookmarking of premetastatic niches. Nat Cell Biol 2006, 8(12):1321-1323. 10.1038/ncb1206-1321, 17139281.
26. Salama I, Malone PS, Mihaimeed F, Jones JL. A review of the S100 proteins in cancer. Eur J Surg Oncol 2008, 34(4):357-364.
27. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008, 54(2):303-314. 10.1016/j.eururo.2008.04.051, 18468779.
28. Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, Wolf JS, Schellhammer PF. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007, 178(6):2314-2330. 10.1016/j.juro.2007.09.003, 17993339.
29. Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA. The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer. Eur Urol 2009, 55(4):815-25. 10.1016/j.eururo.2009.01.002, 19157687.
30. Malmstrom PU, Sylvester RJ, Crawford DE, Friedrich M, Krege S, Rintala E, Solsona E, Di Stasi SM, Witjes JA. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer. Eur Urol 2009, 56(2):247-256. 10.1016/j.eururo.2009.04.038, 19409692.
31. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95(25):14863-14868. 10.1073/pnas.95.25.14863, 24541, 9843981.
32. Dyrskjot L, Zieger K, Real FX, Malats N, Carrato A, Hurst C, Kotwal S, Knowles M, Malmstrom PU, de la Torre M, et al. Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study. Clin Cancer Res 2007, 13(12):3545-3551. 10.1158/1078-0432.CCR-06-2940, 17575217.
33. Radmacher MD, McShane LM, Simon R. A paradigm for class prediction using gene expression profiles. J Comput Biol 2002, 9(3):505-511. 10.1089/106652702760138592, 12162889.
34. Dudoit S, Fridlyand J, Speed TP. Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data. J Am Stat Assoc 2002, 97(457):10.
35. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 2001, 98(26):15149-15154. 10.1073/pnas.211566398, 64998, 11742071.
36. Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003, 95(1):14-18.
37. Rahimi F, Hsu K, Endoh Y, Geczy CL. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8. FEBS J 2005, 272(11):2811-2827. 10.1111/j.1742-4658.2005.04703.x, 15943814.
38. Prieto C, Risueno A, Fontanillo C, De las Rivas J. Human gene coexpression landscape: confident network derived from tissue transcriptomic profiles. PLoS One 2008, 3(12):e3911. 10.1371/journal.pone.0003911, 2597745, 19081792.
39. Thorgeirsson SS, Lee JS, Grisham JW. Molecular prognostication of liver cancer: end of the beginning. J Hepatol 2006, 44(4):798-805. 10.1016/j.jhep.2006.01.008, 16488507.
40. Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y, Voronov E. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 2006, 25(3):387-408. 10.1007/s10555-006-9004-4, 17043764.
41. Yano S, Nokihara H, Yamamoto A, Goto H, Ogawa H, Kanematsu T, Miki T, Uehara H, Saijo Y, Nukiwa T, et al. Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci 2003, 94(3):244-252. 10.1111/j.1349-7006.2003.tb01428.x, 12824917.